Synageva BioPharma (GEVA)

Add to Watchlists
Create an Alert
213.66 -0.93  -0.43% NASDAQ May 29, 12:25PM Delayed 2m USD

Synageva BioPharma Price to Book Value:

10.80 for May 29, 2015

View 4,000+ financial data types

View Full Chart

Synageva BioPharma Price to Book Value Chart

Export Data
Save Image

Synageva BioPharma Historical Price to Book Value Data

View and export this data going back to 1997. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
May 29, 2015 10.80
May 28, 2015 10.85
May 27, 2015 10.90
May 26, 2015 10.82
May 22, 2015 11.02
May 21, 2015 10.91
May 20, 2015 10.79
May 19, 2015 10.72
May 18, 2015 10.75
May 15, 2015 10.69
May 14, 2015 10.74
May 13, 2015 10.69
May 12, 2015 10.74
May 11, 2015 10.75
May 8, 2015 10.81
May 7, 2015 10.83
May 6, 2015 10.28
May 5, 2015 4.845
May 4, 2015 5.029
May 1, 2015 4.998
April 30, 2015 4.648
April 29, 2015 5.104
April 28, 2015 5.176
April 27, 2015 5.185
April 24, 2015 5.484
April 23, 2015 5.416
   
April 22, 2015 5.249
April 21, 2015 5.348
April 20, 2015 5.272
April 17, 2015 5.210
April 16, 2015 5.333
April 15, 2015 5.313
April 14, 2015 5.179
April 13, 2015 5.19
April 10, 2015 5.052
April 9, 2015 4.918
April 8, 2015 4.853
April 7, 2015 4.687
April 6, 2015 4.670
April 2, 2015 4.788
April 1, 2015 4.952
March 31, 2015 4.909
March 30, 2015 7.773
March 27, 2015 7.707
March 26, 2015 7.237
March 25, 2015 7.286
March 24, 2015 7.941
March 23, 2015 8.281
March 20, 2015 8.741
March 19, 2015 9.165
March 18, 2015 9.054

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Price to Book Ratio

Price to book value is a financial ratio used to compare a company's book value to its current market price. Book value is an accounting term denoting the portion of the company held by the shareholders at accounting value (not market value). In other words, book value is the company's total tangible assets less its total liabilities.

The ratio has two calculation methods. In the first way, the company's market capitalization is divided by the company's total book value from its balance sheet. The second way, using per-share values, is to divide the company's current share price by the book value per share. In general, a low price to book value indicates that a stock is undervalued and thus more desirable.

In theory, if you purchased stock with a price to book value less than 1 and the company immediately went bankrupt, you would gain money on your investment. In reality, this may not be true since there are times when liquidation value, or the price at which a company's assets can be sold, is less than the book value of those assets.

For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
Learn More

Advertisement

GEVA Price to Book Value Benchmarks

Companies
Alexion Pharmaceuticals 9.431
Vertex Pharmaceuticals 31.80
Fate Therapeutics 6.083

GEVA Price to Book Value Range, Past 5 Years

Minimum 0.7259 Sep 12 2011
Maximum 11.02 May 22 2015
Average 4.517

GEVA Price to Book Value Excel Add-In Codes

  • Metric Code: price_to_book_value
  • Latest data point: =YCP("GEVA", "price_to_book_value")
  • Last 5 data points: =YCS("GEVA", "price_to_book_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.